Similar personal injury firms in Houston
Prior results do not guarantee a similar outcome. Each case is unique and depends on its own facts.
About The Lanier Law Firm
The Lanier Law Firm, founded by W. Mark Lanier in 1990, is a nationally recognized plaintiffs trial firm with offices in Houston, New York, and Los Angeles. The firm handles mass tort, pharmaceutical liability, product liability, asbestos and mesothelioma, business litigation, and personal injury cases, and has secured over $20 billion in recoveries for clients.
Proven verdicts and settlements won by The Lanier Law Firm
A St. Louis jury in July 2018 awarded 22 women and their families $4.69 billion, the largest U.S. verdict of that year, finding that asbestos in Johnson & Johnson's talcum powder products caused ovarian cancer; a Missouri appellate court upheld $2.11 billion in 2020.
After a six-week federal trial, a jury found three of the nation's largest retail pharmacy chains created a public nuisance by flooding Lake and Trumbull Counties, Ohio with opioid pills, and a judge ordered $650 million to fund a 15-year abatement plan.
A Dallas federal jury awarded $1.04 billion to six California patients harmed by Johnson and Johnson's metal-on-metal Pinnacle hip implants, with W. Mark Lanier leading an eight-week trial that produced one of the largest product-liability verdicts of 2016.
Hours before opening arguments in the first federal opioid bellwether trial, Cuyahoga and Summit counties in Ohio secured a $260 million settlement from distributors AmerisourceBergen, Cardinal Health, and McKesson, plus manufacturer Teva.
A Dallas federal jury awarded six New York patients $247 million against Johnson and Johnson and its DePuy unit, finding that the metal-on-metal Pinnacle hip implant system was defectively designed and that the company concealed known risks from patients and surgeons.
A Louisiana federal jury awarded Terrence Allen $9 billion in punitive damages against Takeda and Eli Lilly after finding they hid Actos's bladder cancer risk for years, with W. Mark Lanier serving as lead trial counsel in the first federal bellwether trial of the massive MDL.
As chair of the plaintiffs' negotiating committee and Liaison Counsel in the Vioxx multidistrict litigation, Russ Herman directed the negotiations that produced a $4.85 billion settlement with Merck resolving approximately 45,000 to 50,000 personal-injury claims.
In early 2014, Biomet agreed to pay at least $56 million to settle about 1,000 federal lawsuits over its M2a 38 and M2a Magnum metal-on-metal hip implants, consolidated in the Northern District of Indiana. Qualifying patients who had the device revised received a base award of $200,000, adjusted by individual factors. Thomas Anapol was court-appointed Co-Lead Counsel with W. Mark Lanier and signed the agreement for the Plaintiffs' Executive Committee. The figure covers many unrelated plaintiffs, is a reported minimum rather than a final total, and is not itemized by person.
A Boston jury found on Sept. 13, 2024 that Cimbar Performance Minerals misrepresented the safety of its Elite Talc 2000 and that its negligence helped cause a Utah man's mesothelioma, which was diagnosed seven years after he received talc during a 2014 pleurodesis. It is the first known verdict on that theory. The jury awarded about $39.1 million, and the trial judge later cut the future pain and suffering item from $21.5 million to $6 million. About $23.6 million stood.
A Los Angeles jury found Meta and Google's YouTube negligent in designing platforms that harmed a young woman identified as K.G.M., who began watching YouTube at age 6 and joined Instagram at 9. On March 25, 2026, it awarded $3 million in compensatory damages, split 70 percent to Meta and 30 percent to YouTube, plus $3 million in punitive damages. It was the first bellwether trial in the coordinated California social media addiction cases.
Prior results do not guarantee a similar outcome. Each case is unique and depends on its own facts.
Proven verdicts and settlements from other Houston firms
Prior results do not guarantee a similar outcome. Each case is unique and depends on its own facts.